Side-by-side comparison of AI visibility scores, market position, and capabilities
World's #1 live casino B2B supplier; €1.045B H1 2025 revenue, 65.8% EBITDA margin. Powers live casino for FanDuel, BetMGM, and 700+ operators globally.
Evolution is a Swedish B2B iGaming company founded in 2006 and listed on Nasdaq Stockholm, providing live dealer casino games and RNG content to online casino operators worldwide. The company develops and operates live casino studios in 20+ countries—including major facilities in Riga (Latvia), Malta, Georgia, Romania, Canada, and the United States—streaming thousands of simultaneous live table games to casino operators globally. Key products include Live Blackjack, Live Roulette, Live Baccarat, and exclusive game shows like Crazy Time, which has become one of the most-played live casino games in history.\n\nEvolution's B2B model licenses its live casino platform to 700+ operators—including FanDuel, BetMGM, Caesars Digital, DraftKings, and virtually every major online casino brand globally—under revenue-share agreements. This asset-light licensing model generates exceptional margins. Evolution has expanded beyond live casino into RNG slots through acquisitions of NetEnt (2020) and Red Tiger Gaming, adding a portfolio of 1,000+ digital slot titles.\n\nEvolution reported H1 2025 revenue of €1.045B (+3.5% YoY), with adjusted EBITDA margin of 65.8%—among the highest in the global gaming industry. Q2 2025 revenue was €524.3M, with live casino contributing €453.7M. Evolution holds approximately 45% of the global live casino B2B market, ahead of Playtech (30%) and Pragmatic Play (25%). The company launched its first Philippines studio and a new São Paulo facility in 2025.
a2z Radiology AI raised $20M in 2025 for its whole-body AI that simultaneously screens for 24+ conditions across CT scans — from incidental cancers to cardiovascular risk — in a single automated read.
a2z Radiology AI has developed a whole-body CT analysis platform that simultaneously screens for over 24 medical conditions across a single CT scan, including incidental cancers, coronary artery disease, aortic aneurysm, bone density loss, and organ abnormalities. The AI acts as a second reader that radiologists can use to catch incidental findings that fall outside the primary reason for a scan — a major source of missed diagnoses.
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.